Med-El cochlear implant is the first to receive FDA approval in single-sided deafness. Candidacy criteria are strict/conservative. Patients must have word scores of 5% or less in the deafened ear. The opposite ear must have normal or mild loss. Research studies suggest that  CIs in this population definitely benefits patients single-sided deafness. The FDA has taken a cautious first step to ensuring this benefit is seen in the general population.

Ready To Get Started?

Dr. Ruffin examining patient

Dr. Ruffin is committed to providing every patient with outstanding care.